474 related articles for article (PubMed ID: 31929855)
21. Oxidative stress and apoptosis: a new treatment paradigm in cancer.
Engel RH; Evens AM
Front Biosci; 2006 Jan; 11():300-12. PubMed ID: 16146732
[TBL] [Abstract][Full Text] [Related]
22. Targeting Oncogenic Nuclear Factor Kappa B Signaling with Redox-Active Agents for Cancer Treatment.
Fouani L; Kovacevic Z; Richardson DR
Antioxid Redox Signal; 2019 Mar; 30(8):1096-1123. PubMed ID: 29161883
[TBL] [Abstract][Full Text] [Related]
23. Glutathione reductase mediates drug resistance in glioblastoma cells by regulating redox homeostasis.
Zhu Z; Du S; Du Y; Ren J; Ying G; Yan Z
J Neurochem; 2018 Jan; 144(1):93-104. PubMed ID: 29105080
[TBL] [Abstract][Full Text] [Related]
24. The role of cellular reactive oxygen species in cancer chemotherapy.
Yang H; Villani RM; Wang H; Simpson MJ; Roberts MS; Tang M; Liang X
J Exp Clin Cancer Res; 2018 Nov; 37(1):266. PubMed ID: 30382874
[TBL] [Abstract][Full Text] [Related]
25. Oxidative Stress-Inducing Anticancer Therapies: Taking a Closer Look at Their Immunomodulating Effects.
Van Loenhout J; Peeters M; Bogaerts A; Smits E; Deben C
Antioxidants (Basel); 2020 Nov; 9(12):. PubMed ID: 33260826
[TBL] [Abstract][Full Text] [Related]
26. Redox regulation of cancer metastasis: molecular signaling and therapeutic opportunities.
Yang W; Zou L; Huang C; Lei Y
Drug Dev Res; 2014 Aug; 75(5):331-41. PubMed ID: 25160073
[TBL] [Abstract][Full Text] [Related]
27. Redox control of cancer cell destruction.
Hegedűs C; Kovács K; Polgár Z; Regdon Z; Szabó É; Robaszkiewicz A; Forman HJ; Martner A; Virág L
Redox Biol; 2018 Jun; 16():59-74. PubMed ID: 29477046
[TBL] [Abstract][Full Text] [Related]
28. Oxidative stress and protein aggregation during biological aging.
Squier TC
Exp Gerontol; 2001 Sep; 36(9):1539-50. PubMed ID: 11525876
[TBL] [Abstract][Full Text] [Related]
29. PRX1 knockdown potentiates vitamin K3 toxicity in cancer cells: a potential new therapeutic perspective for an old drug.
He T; Hatem E; Vernis L; Lei M; Huang ME
J Exp Clin Cancer Res; 2015 Dec; 34():152. PubMed ID: 26689287
[TBL] [Abstract][Full Text] [Related]
30. Current Development of ROS-Modulating Agents as Novel Antitumor Therapy.
Wang N; Wu Y; Bian J; Qian X; Lin H; Sun H; You Q; Zhang X
Curr Cancer Drug Targets; 2017; 17(2):122-136. PubMed ID: 26881931
[TBL] [Abstract][Full Text] [Related]
31. Pharmacological modulation of reactive oxygen species in cancer treatment.
Ribas J; Mattiolo P; Boix J
Curr Drug Targets; 2015; 16(1):31-7. PubMed ID: 25395102
[TBL] [Abstract][Full Text] [Related]
32. The emerging role of reactive oxygen species in cancer therapy.
Renschler MF
Eur J Cancer; 2004 Sep; 40(13):1934-40. PubMed ID: 15315800
[TBL] [Abstract][Full Text] [Related]
33. Mitochondria and Mitochondrial ROS in Cancer: Novel Targets for Anticancer Therapy.
Yang Y; Karakhanova S; Hartwig W; D'Haese JG; Philippov PP; Werner J; Bazhin AV
J Cell Physiol; 2016 Dec; 231(12):2570-81. PubMed ID: 26895995
[TBL] [Abstract][Full Text] [Related]
34. Harnessing altered oxidative metabolism in cancer by augmented prooxidant therapy.
Firczuk M; Bajor M; Graczyk-Jarzynka A; Fidyt K; Goral A; Zagozdzon R
Cancer Lett; 2020 Feb; 471():1-11. PubMed ID: 31811907
[TBL] [Abstract][Full Text] [Related]
35. Clinically Evaluated Cancer Drugs Inhibiting Redox Signaling.
Kirkpatrick DL; Powis G
Antioxid Redox Signal; 2017 Feb; 26(6):262-273. PubMed ID: 26983373
[TBL] [Abstract][Full Text] [Related]
36. Design and discovery of novel quinazolinedione-based redox modulators as therapies for pancreatic cancer.
Pathania D; Sechi M; Palomba M; Sanna V; Berrettini F; Sias A; Taheri L; Neamati N
Biochim Biophys Acta; 2014 Jan; 1840(1):332-43. PubMed ID: 23954204
[TBL] [Abstract][Full Text] [Related]
37. Acute oxidant damage promoted on cancer cells by amitriptyline in comparison with some common chemotherapeutic drugs.
Cordero MD; Sánchez-Alcázar JA; Bautista-Ferrufino MR; Carmona-López MI; Illanes M; Ríos MJ; Garrido-Maraver J; Alcudia A; Navas P; de Miguel M
Anticancer Drugs; 2010 Nov; 21(10):932-44. PubMed ID: 20847644
[TBL] [Abstract][Full Text] [Related]
38. Induction of reactive oxygen species: an emerging approach for cancer therapy.
Zou Z; Chang H; Li H; Wang S
Apoptosis; 2017 Nov; 22(11):1321-1335. PubMed ID: 28936716
[TBL] [Abstract][Full Text] [Related]
39. Reactive oxygen species in cancer biology and anticancer therapy.
Yang Y; Karakhanova S; Werner J; Bazhin AV
Curr Med Chem; 2013; 20(30):3677-92. PubMed ID: 23862622
[TBL] [Abstract][Full Text] [Related]
40. Redox Potential and ROS-Mediated Nanomedicines for Improving Cancer Therapy.
Glass SB; Gonzalez-Fajardo L; Beringhs AO; Lu X
Antioxid Redox Signal; 2019 Feb; 30(5):747-761. PubMed ID: 28990403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
